DENTSPLY (XRAY) Fundamental Analysis: Revenue, Earnings & Valuation

4.97 / 10

Netural

Fundamentals rate neutral with a 5/10 score; profit‑to‑market and cash‑to‑market ratios are modestly positive, while ROE, ROA and returns are negative, leading to a cautious outlook.

Analysis Checks(10/10)

ROA (%)

Value-10.70

Score2/3

Weight2.95%

1M Return0.63%

Annualized return on equity (%)

Value-36.45

Score2/3

Weight6.55%

1M Return1.35%

Profit-MV

Value0.68

Score2/3

Weight16.41%

1M Return3.26%

Cash-UP

Value0.03

Score3/3

Weight16.98%

1M Return3.34%

Annualized net profit margin on total assets (%)

Value-10.70

Score2/3

Weight2.95%

1M Return0.63%

ROE (diluted) (%)

Value-44.66

Score2/3

Weight5.31%

1M Return1.11%

Asset-MV

Value-0.55

Score2/3

Weight17.53%

1M Return3.42%

ROE (%)

Value-36.45

Score2/3

Weight6.55%

1M Return1.35%

Cash-MV

Value0.44

Score3/3

Weight14.23%

1M Return2.65%

Net profit / Total profit (%)

Value123.05

Score3/3

Weight10.52%

1M Return2.09%

Is XRAY undervalued or overvalued?

XRAY scores 4.97/10 on fundamentals and holds a Fair valuation at present. Backed by its -36.43% ROE, -16.25% net margin, -3.83 P/E ratio, 1.71 P/B ratio, and 33.04% earnings growth, these metrics solidify its Netural investment rating.